Status:
ENROLLING_BY_INVITATION
RNA Assays for Endometriosis Detection and Diagnosis
Lead Sponsor:
Wren Laboratories LLC
Collaborating Sponsors:
University of Cape Town
Conditions:
Endometriosis
Eligibility:
FEMALE
20-35 years
Brief Summary
Endometriosis is a common disease that affects up to 10% of women of reproductive age. Diagnosis, however, is typically delayed (up to 12 years) and is usually made after surgery. A key unmet need the...
Detailed Description
Endometriosis is a common disease that affects up to 10% of women of reproductive age. Diagnosis, however, is typically delayed (up to 12 years) and is typically made after surgery. A key unmet need t...
Eligibility Criteria
Inclusion
- For the endometriosis cohort
- a history of infertility more than 1 year
- age 20-35 years
- normal liver and kidney function, without gynaecological and other systemic disease
- Inclusion criteria for controls include normo-ovulatory history, aged between 20-35 years, who exhibit normal liver and kidney function, and do not have any systemic diseases including autoimmune disease.
- \-
Exclusion
- For the endometriosis cohort
- polycystic ovary syndrome, hyperprolactinemia
- severe cardiovascular system, liver, kidney, and hematopoietic system disease
- autoimmune disease
- uterine fibroids, endometritis, non-vegetative ovarian cysts, ovarian malignancies, and internal genital tuberculosis
- Exclusion criteria for the controls includes gynaecological malignancies and genital tuberculosis.
- \-
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06907303
Start Date
January 1 2024
End Date
December 31 2026
Last Update
April 2 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Wren Laboratories
Branford, Connecticut, United States, 06405
2
University of Cape Town
Cape Town, South Africa